Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Oragenics Inc fell by 7.94m. Cash Flow from Financing totalled 283.88k or 754.00% of revenues. In addition the company used 7.29m for operations while cash used for investing totalled 936.28k.
Cash flow per share | -6.02 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.2377 |
---|---|
Tangible book value per share | 0.2377 |
More ▼
Balance sheet in USDView more
Current ratio | 1.17 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼